No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
Sugi Holdings Co.,Ltd. operates drugstores in Japan. The company also provides self-care support services, including meal delivery, cancer and other health checkups, specific health guidance, health information, and community comprehensive agreements; health care support, such as medicine support, home-visit dispensing and nursing, prevention programs, shopping assistance, and mobility support services. In addition, it engages in drugstore operation, dispensing pharmacy operation, medical consultation, business in foreign countries, Chinese medicine pharmacy operations, disease prevention and health support, promotion of disabled employment, home visit nursing and elderly home-care support, support for commencement of medical practice, comprehensive staff agency service, and support business for pharmacy operations. Sugi Holdings Co.,Ltd. was founded in 1976 and is headquartered in Obu, Japan.
www.sugi-hd.co.jpNo one on the platform currently holds 7649.T.
No tracked institution reports a position in 7649.T as of their last filing.
No one on the platform has traded 7649.T yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 17.7% | 14.2% | 16.5% | — | — | — |
| Rev. Growth % | 15.1% | 10.9% | ||||
| Profit Margin % | 4.5% | 3.3% | 3.4% | |||
| Free Cash Flow Margin % | 6.3% | 2.0% | 2.3% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $1.10T | +9.4% | $89.21 | $80.57–$94.17 | — | 7 |
| 2028 | $1.21T | +9.2% | $100.07 | $91.28–$105.96 | — | 7 |
| 2029 | $1.28T | +5.9% | $109.90 | $102.17–$114.49 | — | 6 |
| 2030 | $1.36T | +6.2% | $124.25 | $120.96–$129.21 | — | 2 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-09 | $21.43 | $19.07 | -11.0% |
| 2026-04-09 | $23.71 | $25.74 | +8.6% |
| 2026-01-08 | $20.93 | $19.48 | -6.9% |
| 2025-10-09 | $24.07 | $20.43 | -15.1% |
| 2025-07-10 | $21.23 | $58.64 | +176.2% |
| 2025-04-10 | $19.50 | $18.30 | -6.2% |
| 2025-01-09 | $16.46 | $16.57 | +0.7% |
| 2024-09-24 | $16.86 |
| $19.17 |
| +13.7% |
| $4057.00 |
| -0.64% |
| $385.3B |
| — |
| 4506.TSumitomo Pharma Co., Ltd. | $1582.50 | +0.96% | $709.9B | — |
| 4536.TSanten Pharmaceutical Co., Ltd. | $1742.00 | -0.06% | $560.4B | — |
Source: Financial Modeling Prep · peers by sector/industry